Poop pills could stop deadly transplant complication
NCT ID NCT04745221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether transplanting a patient's own fecal bacteria can prevent acute graft-versus-host disease (GVHD) after a stem cell transplant. GVHD is a serious condition where donor cells attack the patient's body. The trial will enroll 100 bone marrow transplant patients and compare those who receive the fecal transplant to those who do not.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VERSUS HOST DISEASE, ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ye Zhao
RECRUITINGSuzhou, Jiangsu, 215006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.